MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Globus Medical Company Profile (NASDAQ:GMED)

Consensus Ratings for Globus Medical (NASDAQ:GMED) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $29.43 (17.81% upside)

Analysts' Ratings History for Globus Medical (NASDAQ:GMED)
Show:
DateFirmActionRatingPrice TargetActions
2/25/2016Canaccord GenuityReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Leerink SwannReiterated RatingOutperform$32.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016JMP SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016Bank of AmericaDowngradeBuy -> Underperform$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015OppenheimerInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015Morgan StanleyReiterated RatingOverweight$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015Goldman SachsLower Price Target$27.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2015Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015WallachBeth CapitalBoost Price TargetBuy$26.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Piper JaffrayInitiated CoverageOverweight$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014GabelliInitiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/4/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha